Home ›
Trademark Categories ›
Pharmaceuticals ›
2018 ›
CL ›
CLERDIYA
Trademark search for:
CLERDIYA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2018-02-05 — Application filed
2018-02-08 — Application filed
2018-02-13 — Application filed
2018-03-29 — Assigned to examiner
2018-04-05 — Approved for pub - principal register
2018-04-18 — Notification of notice of publication e-mailed
2018-05-08 — Published for opposition
2018-05-08 — Official gazette publication confirmation e-mailed
2018-07-03 — Noa e-mailed - sou required from applicant
2019-01-03 — Sou extension 1 filed
2019-02-04 — Application abandoned
2019-02-04 — Teas petition to revive received
2019-02-04 — Petition to revive-granted
2019-02-04 — Sou extension received with teas petition
2019-02-04 — Notice of revival - e-mailed
2019-03-19 — Case assigned to intent to use paralegal
2019-03-19 — Sou extension 1 granted
2019-03-20 — Notice of approval of extension request e-mailed
2019-06-26 — Sou teas extension received
2019-06-26 — Sou extension 2 filed
2019-06-26 — Sou extension 2 granted
2019-06-28 — Notice of approval of extension request e-mailed
2020-01-03 — Sou teas extension received
2020-01-03 — Sou extension 3 filed
2020-01-03 — Sou extension 3 granted
2020-01-07 — Notice of approval of extension request e-mailed
2020-06-14 — Teas revoke/app/change addr of atty/dom rep received
2020-06-14 — Attorney/dom.rep.revoked and/or appointed
2020-06-14 — Teas change of correspondence received
2020-06-23 — Sou teas extension received
2020-06-23 — Sou extension 4 filed
2020-06-23 — Sou extension 4 granted
2020-06-25 — Notice of approval of extension request e-mailed
2021-01-01 — Sou teas extension received
2021-01-01 — Sou extension 5 filed
2021-01-22 — Sou extension 5 granted
2021-01-23 — Notice of approval of extension request e-mailed
2021-08-09 — Application abandoned
2021-08-09 — Application abandoned
2021-08-09 — Final status recorded
Owner Information
Alnylam Pharmaceuticals, Inc.
Cambridge , MA
Alnylam Pharmaceuticals, Inc.
Cambridge , MA
Correspondent
Timothy H. Hiebert Womble Bond Dickinson (US) LLP 470 Atlantic Ave., Suite 600 Boston, MA 02210-2228 UNITED STATES
Filing Details
Filing Date:
2018-02-05
Status Date:
2021-08-09
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.